Miscellaneous
The Latest Malaria News, in 60 Seconds. Researchers evaluate the immunogenicity of the AGS-v vaccine which targets saliva produced by Anopheles gambiae mosquitoes. More: www.fightmalaria.uk/MalariaMinute
Mosquito Saliva Vaccine Evaluated in Phase 1 Trial
Share:
Listens: 0